Browse by Audience
Skip to content
Papers of the Week
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
Abstract
Migraine is the second leading cause of years lived with disability after back pain. Poor tolerability, contraindications, drug-drug interactions and efficacy limited to a subpopulation make new approaches necessary for the acute and preventive treatment of migraine. The study of the calcitonin-gene-related peptide (CGRP) pathway over the last decades is a good example of translational medicine leading to directed therapies for patients.